TurnerTrends Stock Rating Report for AGEN
Data valid for week beginning August 25, 2008
|
AGEN [News]
|
Antigenics Inc
|
Company Profile
"Antigenics, Inc., a biotechnology company, engages in the research and development of technologies and product candidates to treat cancers and infectious diseases. Its investigational product portfolio includes Oncophage (vitespen), a patient-specific therapeutic cancer vaccine approved in Russia- QS-21, an adjuvant being evaluated by its collaborative partners in approximately 15 clinical stage vaccines- Aroplatin (L-NDDP), a liposomal, third-generation platinum chemotherapeutic- and AG-707, a heat shock protein based therapeutic vaccine for the treatment of genital herpes. The company was founded in 1994. It was formerly known as Antigenics L.L.C. and changed its name to Antigenics, Inc. in 2000. Antigenics, Inc. is headquartered in New York, New York."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Thu, 14 Aug 2008 13:04:17 Etc/GMT | ANTIGENICS INC /DE/ Financials (EDGAR Online Financials) | | Fri, 8 Aug 2008 16:30:03 Etc/GMT | ANTIGENICS INC /DE/ Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | Sat, 2 Aug 2008 13:19:25 Etc/GMT | New Star Analyst Rankings for ANTIGENICS INC (StarMine) | | Thu, 31 Jul 2008 15:00:00 Etc/GMT | Antigenics Inc. Earnings Call scheduled for 11:00 am ET today (CCBN) | | Thu, 31 Jul 2008 11:40:10 Etc/GMT | ANTIGENICS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib (EDGAR Online) | | Thu, 31 Jul 2008 11:07:14 Etc/GMT | Q2 2008 Antigenics Inc. Earnings Release - Before Market Open (CCBN) | | Thu, 31 Jul 2008 11:00:00 Etc/GMT | Antigenics Reports Second Quarter 2008 Financial Results (Business Wire) | | Thu, 24 Jul 2008 11:00:00 Etc/GMT | Antigenics to Report Second Quarter 2008 Financial Results on July 31, 2008; Conference Call to Follow (Business Wire) | | Thu, 10 Jul 2008 17:33:19 Etc/GMT | ANTIGENICS INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online) | | Fri, 6 Jun 2008 16:38:53 Etc/GMT | ANTIGENICS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online) | | Fri, 9 May 2008 20:28:08 Etc/GMT | ANTIGENICS INC /DE/ Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | Thu, 1 May 2008 15:00:00 Etc/GMT | Antigenics Inc. Earnings Call scheduled for 11:00 am ET today (CCBN) | | Thu, 1 May 2008 11:40:11 Etc/GMT | ANTIGENICS INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib (EDGAR Online) | | Fri, 25 Apr 2008 20:56:16 Etc/GMT | ANTIGENICS INC /DE/ Files SEC form 8-K, Other Events (EDGAR Online) | | Tue, 22 Apr 2008 18:55:16 Etc/GMT | Betting on Approval for This Orphan Drug (at Motley Fool) | | Fri, 18 Apr 2008 20:06:45 Etc/GMT | More Good News About Cancer Vaccines (at Motley Fool) | | Wed, 16 Apr 2008 21:39:48 Etc/GMT | Pfizer Goes Bargain Hunting (at Forbes.com) | | Sat, 12 Apr 2008 14:19:42 Etc/GMT | Feuerstein's Biotech-Stock Mailbag (at TheStreet.com) | | Fri, 11 Apr 2008 18:31:39 Etc/GMT | U.S. Cancer Vaccine Gets The Green Light - In Russia (at Investopedia) | | Thu, 10 Apr 2008 20:05:14 Etc/GMT | ANTIGENICS INC /DE/ Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (EDGAR Online) | News provided by Yahoo! Finance |
|
